EPI-001
EPI-001 is a small molecule that antagonizes the androgen receptor N-terminal domain (IC50 ~6 μM) and acts as a selective PPARγ modulator. It has been utilized in preclinical research to study prostate cancer mechanisms and metabolic pathways in both cellular and animal models.
Product Specifications
CAS Number
227947-06-0
Product Name Alternative
Domain, Apoptosis, anti-tumor, AndrogenReceptor, Androgen Receptor, Androgen, amino-terminal, NTD, inhibit, Inhibitor, EPI001, EPI-001, EPI 001, Receptor, PPAR, Peroxisome proliferator-activated receptors, PPARγ, transactivation
Field of Research
Cell Biology, Metabolism Research, Molecular Biology
Purity
99.00% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:55 mg/mL (139.28 mM) ; Ethanol:70 mg/mL (177.26 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.06 mM)
Smiles
CC (C) (c1ccc (OCC (O) CO) cc1) c1ccc (OCC (O) CCl) cc1
Molecular Formula
C21H27ClO5
Molecular Weight
394.89
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV743567 1.0 µg DNA
RN5S131 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details